Claim Missing Document
Check
Articles

Found 3 Documents
Search

Penatalaksanaan Bantuan Hidup Dasar (BHD) Pada Masyarakat Awam (Santri Ponpes Yambuul Hikmah) Di Andong Boyolali Akhmad Rifai; Muh Ilyas
(JKG) Jurnal Keperawatan Global Vol 3 No 2 (2018): JURNAL KEPERAWATAN GLOBAL
Publisher : Poltekkes Kemenkes Surakarta

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.37341/jkg.v3i2.58

Abstract

Abstract Background: Heart disease is the number one cause of death, accounting for 39% of all deaths in the world. Basic Life Assistance (BLS) should be given to victims who suffer from stopping breathing, cardiac arrest, and bleeding. The purpose of this study was to determine the ability of Basic Life Support Skills (BLS) santri Ponpes Yambuul Hikmah in Andong Boyolali. Methods: This research is an experimental research with approach of Pre-Tes-Post Test Group design. through testing of research hypotheses. The population of this study is the people of cloud (santri Ponpes Yambul Hikmah)amounted to 50 respondents. Statistical test in pairs of groups using nonparametric Wilcoxon test. Result: Based on Wilcoxon test results it can be concluded that 50 respondents who Basic Life support Assistance (BLS) training can be drawn conclusion that the majority of santri have good knowledge in terms of emergency handling capability especially Basic Life Support with p value 0,001 which means there is a difference that takes place between before and after training. Conclusion: put forward in this research is education and training BLS of santri continue to be held at otherboarding school to improve the ability of BLS.
The survival rate comparison of non small cell lung carcinoma patients who are given by epidermal growth factor receptor-tyrosin kinase inhibitor and those given by first-line chemotherapy treatment Hasan Nyambe; Arif Santoso; Nur Ahmad Tabri; Harun Iskandar; Muh Ilyas; Edward Pandu Wiriyansyah
Nusantara Medical Science Journal Volume 6 Issue 2, July - December 2021
Publisher : Faculty of Medicine, Hasanuddin University.

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.20956/nmsj.v6i2.18857

Abstract

Introduction. Lung cancer is the type of non-small cell carcinoma (NSCLC) consists of non-squamous and squamous. Non-small cell lung cancer of non squamous types consist of adenocarcinoma and large cell carcinoma. Currently, lung cancer therapy is highly developed of chemotherapeutic agents to targeted therapy especially EGFR-TKI. This study aims to assess the survival rate of NSCLC patients who receive first line chemotherapy and those who recieve EGFR-TKI therapy at Wahidin Sudirohusodo hospital. Methods. This study is a retrospective study between 2017 to 2019 from the medical records of NSCLC patients who receive first-line chemotherapy and thise who recieve EGFR-TKI. Patients with platinum-based chemotherapy and EGFR-TKI with gefitinib therapy 1x250 mg/day or erlotinib 1x150mg/day and or afatinib 1x40 mg/day. Survival rate assessed from start to erect the diagnosis until the patient dies or when the  study is     discontinued. Result. From 239 subject of NSCLC patients consisted of 135 patients who receive first-line chemotherapy, and 104 patients are treate with EGFR-TKI. Based on the characteristics of the patients, most are more than 40 years old (chemotherapy 124 (91.9%) and EGFR-TKI 101 (97.1%) with the male gender that dominates (chemotherapy 98 (72.6%), EGFR-TKI 64 (61.5%). Smoking patients who received first-line chemotherapy are 65.2% and 61.5% of EGFR-TKIs with chemotherapy highest IB (severe IB 28.9%) and for EGFR-TKI (moderate IB are 26.9%). 73.2% of adenocarcinoma histology type with a predominance of stage IV 86.6% (83.7% for chemotherapy and EGFR-TKI 90.4%). Survival rate of patients are 98,7% for 6 months survival, 1 year survival rate is 94.1% and 2 years survival rate of 24.3%. Median survival patients who receiving EGFR-TKI longer than they received first- line chemotherapy (21 months versus 20 months). The 18 months PFS showed that patients treated with EGFR-TKI were 15 months, while patients receiving chemotherapy was 11 months. (P 0.000). Conclusion. Survival rates in NSCLC patients with EGFR-TKI therapy had significantly the highest survival rates compared with all other chemotherapy. Progression was faster in patients with first-line chemotherapy than EGFR-TKI. The factors that most influence the survival rate is type of therapy with p value<0.05.
PENERAPAN DISCOVERY LEARNING UNTUK MENINGKATKAN HASIL BELAJAR PESERTA DIDIK KELAS XI IPS 3 MAN 2 MAKASSAR Muh Ilyas
JURNAL ILMIAH RESEARCH STUDENT Vol. 1 No. 4 (2024): Maret
Publisher : CV. KAMPUS AKADEMIK PUBLISING

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.61722/jirs.v1i4.1056

Abstract

This research is a type of classroom action research (action research) to improve the learning outcomes of Al-Quran Hadith students in class XII IPS 3 MAN 2 Makassar 2019/2020 by using discovery learning. This research was carried out in two cycles, namely cycle I and cycle II. These two cycles are a series of interrelated activities. The research subjects were 37 students in class XII IPS 3. The data obtained, namely student activities and learning outcomes, were analyzed using descriptive statistics. The results showed that activity in the positive aspects increased significantly from cycle 1 to cycle II, and the negative aspects decreased. Based on the learning results in cycle 1, it was proven that 78.3% had not yet completed and 21.6% had not yet completed. Based on the percentage of completeness, it has not reached 90% completeness, so the basis for continuing cycle II, cycle II is to perfect the reflection treatment from cycle I, while activities that measure character values have increased by 100% and learning outcomes in cycle II have reached 100% completeness. Shows that the application of discovery learning Matari, positive optimistic thinking, patiently facing tests and trials with a smile can improve the learning outcomes of students in class.